Last reviewed · How we verify
NCT05363410
Micronutrient Supplement for Nurse Burnout
NA trial testing MagnéVie B6® in Burnout, Professional in 88 participants. Status unknown.
30 September 2022
Quick facts
| Lead sponsor | Nutraceuticals Research Institute |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 88 |
| Start date | 1 May 2022 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 April 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- MagnéVie B6®
- Placebo
Conditions studied
- Burnout, Professional — all drugs for Burnout, Professional →
- Stress, Psychological — all drugs for Stress, Psychological →
Sponsor
Nutraceuticals Research Institute
Who can join
Adults 20 to 59, female only, with Burnout, Professional or Stress, Psychological. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to confirm and quantify the ability of an 8-week intervention with a supplement containing magnesium citrate and vitamin B6 to reduce anxiety, stress, and burnout among nurses working full time in hospitals and urgent care centers during the COVID-19 Pandemic.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05363410
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Burnout, Professional
Currently open trials in the same condition.
- NCT07221422 — The PREGNANT (Pregnant Resident Empowerment, GuidaNce, and Advocacy iN Training) Coaching Project · NA · recruiting
- NCT07423468 — Developing Competency Awareness and Clinical Coordination in a Neonatal Unit · NA · active not recruiting
- NCT07262372 — Supervision in Substance Use Disorder Treatment Programs · NA · recruiting
- NCT07089160 — Decision Fatigue and Emotional Exhaustion Among Anesthesiologists · recruiting
- NCT05942469 — Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST) · NA · recruiting
Other Nutraceuticals Research Institute trials
Trials by the same sponsor.
- NCT07210229 — The Effectiveness of a Proprietary Ashwagandha Extract on Menopausal Symptoms: A Three-Arm Randomized, Double-Blinded, P · NA · not yet recruiting
- NCT06919328 — Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+ · NA · recruiting
- NCT06793891 — Effects of Ashwagandha Extract on Stress Levels · NA · recruiting
- NCT06894108 — The Effectiveness of a Proprietary of a Botanical Extract on Sleep Quality · NA · completed
- NCT06382688 — IV Administration of ChromaDex's Niagen® as Compared to NAD+ · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05363410 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nutraceuticals Research Institute
- Last refreshed: 5 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05363410.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing